X4 Pharmaceuticals (XFOR) Misses Q2 EPS by 17c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q2 EPS of ($0.33), $0.17 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $-55.7 million.

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue